Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

This study has suspended participant recruitment.
(Pending Safety Amendment)
Sponsor:
Collaborators:
Advaxis, Inc.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Gynecologic Oncology Group
ClinicalTrials.gov Identifier:
NCT01266460
First received: December 23, 2010
Last updated: May 31, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2018 (Final data collection date for primary outcome measure)